NPPA issued a notification regarding the fixation of the retail price of Ceftriaxone Sodium IP (Sterile) eq. to Anhydrous Ceftriaxone 1000 mg + Sulbactam Sodium IP (Sterile) eq. to Sulbactam 500 mg

Jun 07, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on June 04, 2024, issued a notification regarding the fixation of the retail price of Ceftriaxone Sodium IP (Sterile) eq. to Anhydrous Ceftriaxone 1000 mg + Sulbactam Sodium IP (Sterile) eq. to Sulbactam 500 mg.

The following has been stated: -

•Each Vial Contains Ceftriaxone Sodium IP (Sterile) eq. to Anhydrous Ceftriaxone 1000 mg + Sulbactam Sodium IP (Sterile) eq. to Sulbactam 500 mg for M/s. Aqua Vitoe Laboratories (Manufacturer) & M/s Orchid Pharma Ltd. (Marketer) and the retail price is 153.06 (Rs.)

[Notification No. 19(4040) /2024/DP/NPPA/DIV.III/8239/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT